Here, we are going to share Jagsonpal Pharma Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.
Jagsonpal Pharmaceuticals Ltd. is a famous Indian pharmaceutical company that focuses on the discovery, production, and marketing of healthcare goods.
It focuses on specialized treatment areas such as hormone therapy, orthopedics, and pain management.
Jagsonpal Pharma Share Key Information
| Company Name | Jagsonpal Pharma |
| Headquarters | |
| Sectors | Pharmaceuticals |
| Market Cap | ₹ 2,018.05 Cr. |
| No. of Shares | 2.65 Cr. |
| Book Value | ₹74.34 |
| Dividend Yield | 0.66% |
| ROCE | 17.72% |
| ROE | 14.02% |
| Face Value | ₹5 |
| Sales Growth | -11.83% |
| Profit Growth | -15.94% |
Jagsonpal Pharma Business Sector
- Therapeutic Focus: Jagsonpal operates in specialized therapeutic segments like hormone replacement, orthopedics, and gynecology, offering products that address unmet medical needs.
- Product Range: The portfolio includes branded generic formulations and specialty pharmaceuticals.
- Market Presence: The company has a robust distribution network across India and select export markets.
Board Members
- Mr. Manmohan Singh Luthra – Chairman & Managing Director
- Mr. Amrik Singh Luthra – Executive Director
- Mr. Gurinder Singh Luthra – Non-Executive Director
- Ms. Navneet Kaur Luthra – Independent Director
- Mr. Ashok Kumar Malhotra – Independent Director
- Mr. Dinesh Kumar Sood – Independent Director
- Ms. Ritu Malhotra – Independent Director
Jagsonpal Pharma Share Quarterly Results
| PARTICULARS | Jun 2024 (Cr.) | Sep 2024 (Cr.) |
|---|---|---|
| Net Sales | 61.44 | 74.69 |
| Total Expenditure | 51.20 | 58.41 |
| Operating Profit | 10.24 | 16.29 |
| Other Income | 1.44 | 1.65 |
| Interest | 0.22 | 0.23 |
| Depreciation | 1.07 | 2.34 |
| Exceptional Items | -3.29 | 0 |
| Profit Before Tax | 7.11 | 15.37 |
| Tax | 1.78 | 3.91 |
| Profit After Tax | 5.33 | 11.46 |
| Adjusted EPS (Rs) | 2.01 | 4.33 |
Jagsonpal Pharma Company Profits and Losses
| PARTICULARS | Mar 2023 (Cr.) | Mar 2024 (Cr.) |
|---|---|---|
| Net Sales | 236.71 | 208.70 |
| Total Expenditure | 202.56 | 185.64 |
| Operating Profit | 34.15 | 23.07 |
| Other Income | 5.73 | 9.28 |
| Interest | 0.41 | 0.81 |
| Depreciation | 1.21 | 1.66 |
| Exceptional Items | -3.46 | 0 |
| Profit Before Tax | 34.81 | 29.87 |
| Tax | 8.09 | 7.41 |
| Net Profit | 26.72 | 22.46 |
| Adjusted EPS (Rs.) | 10.20 | 8.50 |
Jagsonpal Pharma Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹740 | ₹785 |
| 2026 | ₹791 | ₹842 |
| 2027 | ₹845 | ₹932 |
| 2028 | ₹935 | ₹1022 |
| 2029 | ₹1026 | ₹1115 |
| 2030 | ₹1121 | ₹1249 |
| 2035 | ₹1524 | ₹1698 |
| 2040 | ₹2240 | ₹2490 |
Jagsonpal Pharma Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹740 |
| February 2025 | ₹745 |
| March 2025 | ₹749 |
| April 2025 | ₹753 |
| May 2025 | ₹755 |
| June 2025 | ₹759 |
| July 2025 | ₹762 |
| August 2025 | ₹763 |
| September 2025 | ₹771 |
| October 2025 | ₹777 |
| November 2025 | ₹782 |
| December 2025 | ₹785 |
Based on the 2025 forecast, the initial target of Jagsonpal Pharma share can could be ₹740 and by the end of the year, the share price target is estimated to reach ₹785.
Jagsonpal Pharma Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹791 |
| February 2026 | ₹795 |
| March 2026 | ₹799 |
| April 2026 | ₹805 |
| May 2026 | ₹811 |
| June 2026 | ₹805 |
| July 2026 | ₹817 |
| August 2026 | ₹821 |
| September 2026 | ₹825 |
| October 2026 | ₹830 |
| November 2026 | ₹833 |
| December 2026 | ₹842 |
Based on the 2026 forecast, the initial target of Jagsonpal Pharma share can could be ₹791 and by the end of the year, the share price target is estimated to reach ₹842.
Jagsonpal Pharma Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹845 |
| February 2027 | ₹846 |
| March 2027 | ₹853 |
| April 2027 | ₹865 |
| May 2027 | ₹870 |
| June 2027 | ₹881 |
| July 2027 | ₹897 |
| August 2027 | ₹904 |
| September 2027 | ₹910 |
| October 2027 | ₹920 |
| November 2027 | ₹924 |
| December 2027 | ₹932 |
Based on the 2027 forecast, the initial target of Jagsonpal Pharma share can could be ₹845 and by the end of the year, the share price target is estimated to reach ₹932.
Jagsonpal Pharma Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹935 |
| February 2028 | ₹936 |
| March 2028 | ₹944 |
| April 2028 | ₹956 |
| May 2028 | ₹962 |
| June 2028 | ₹972 |
| July 2028 | ₹988 |
| August 2028 | ₹995 |
| September 2028 | ₹1000 |
| October 2028 | ₹1011 |
| November 2028 | ₹1014 |
| December 2028 | ₹1022 |
Based on the 2028 forecast, the initial target of Jagsonpal Pharma share can could be ₹935 and by the end of the year, the share price target is estimated to reach ₹1022.
Jagsonpal Pharma Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹1026 |
| February 2029 | ₹1027 |
| March 2029 | ₹1034 |
| April 2029 | ₹1046 |
| May 2029 | ₹1052 |
| June 2029 | ₹1062 |
| July 2029 | ₹1078 |
| August 2029 | ₹1086 |
| September 2029 | ₹1090 |
| October 2029 | ₹1102 |
| November 2029 | ₹1105 |
| December 2029 | ₹1115 |
Based on the 2029 forecast, the initial target of Jagsonpal Pharma share can could be ₹1026 and by the end of the year, the share price target is estimated to reach ₹1115.
Jagsonpal Pharma Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹1121 |
| February 2030 | ₹1135 |
| March 2030 | ₹1142 |
| April 2030 | ₹1152 |
| May 2030 | ₹1162 |
| June 2030 | ₹1177 |
| July 2030 | ₹1189 |
| August 2030 | ₹1195 |
| September 2030 | ₹1205 |
| October 2030 | ₹1224 |
| November 2030 | ₹1235 |
| December 2030 | ₹1249 |
Based on the 2030 forecast, the initial target of Jagsonpal Pharma share can could be ₹1121 and by the end of the year, the share price target is estimated to reach ₹1249.
Jagsonpal Pharma Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹1524 |
| April 2035 | ₹1598 |
| July 2035 | ₹1610 |
| October 2035 | ₹1645 |
| December 2035 | ₹1698 |
Based on the 2035 forecast, the initial target of Jagsonpal Pharma share can could be ₹1524 and by the end of the year, the share price target is estimated to reach ₹1698.
Jagsonpal Pharma Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹2240 |
| April 2040 | ₹2350 |
| July 2040 | ₹2395 |
| October 2040 | ₹2435 |
| December 2040 | ₹2490 |
Based on the 2040 forecast, the initial target of Jagsonpal Pharma share can could be ₹2240 and by the end of the year, the share price target is estimated to reach ₹#2490.
Jagsonpal Pharma Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 67.97% |
| FIIs | 2.3% |
| DIIs | 0.11% |
| Others | 0% |
| Public | 29.62% |
Jagsonpal Pharma Company Competitors
- SMS Pharmacuticals
- TTK healthcare
- beta Drugs
- Vimta Labs
- Syncom Formulations
Bull Case of Jagsonpal Pharma (Reasons to Invest)
Niche Focus: Strong specialization in therapeutic areas with less competition ensures sustained demand.
Growing Market: India’s increasing healthcare expenditure and focus on specialty care support long-term growth.
Operational Efficiency: Streamlined operations and effective cost control measures enhance profitability.
Bear Case of Jagsonpal Pharma (Risks Involved)
Regulatory Risks: Dependence on government policies and drug price controls can impact margins.
Competition: Intense competition from established players in the pharmaceutical sector like Sun Pharma, Dr Reddy, Mankind etc.
Economic Dependency: Sales linked to healthcare spending, which can be affected by economic downturns.
Jagsonpal Pharma Share Price Target: FAQ
What will be the target of Jagsonpal Pharma Share for the year 2025?
By the end of the year 2025, its share price can reach ₹785.
What will be the target of Jagsonpal Pharma Share for the year 2026?
By the end of the year 2026, its share price can reach ₹842.
What will be the target of Jagsonpal Pharma Share for the year 2027?
By the end of the year 2027, its share price can reach ₹932.
What will be the target of Jagsonpal Pharma Share for the year 2028?
By the end of the year 2028, its share price can reach ₹1022.
What will be the target of Jagsonpal Pharma Share for the year 2029?
By the end of the year 2029, its share price can reach ₹1115.
What will be the target of Jagsonpal Pharma Share for the year 2030?
By the end of the year 2030 its share price can reach ₹1249.
What is the Current market cap of Jagsonpal Pharma company?
At present the market cap of this company is ₹ 2,018.05 Cr.
What is the NSE symbol of Jagsonpal Pharma company?
The symbol of this company in NSE exchange is JAGSNPHARM.
What is the BSE symbol of Jagsonpal Pharma company?
The symbol of this company in BSE exchange is 507789.
